RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab
Ruanyun Edai Technology (RYET) licensed its Cogni AI platform exclusively to BioNexus Gene Lab for Malaysia's healthcare sector. The agreement includes a 10% royalty on qualifying receipts and a recip
Yahoo Finance · 2026-10-04 15:42 UTC